speb/financial-data huggingface dataset:
CBNA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 118000.00
CBNA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 6561817.00
CBNA income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.70
CBNA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 4584000.00
CBNA cash_flow (quarterly, 2025-06-30) — End Cash Position: 377264000.00
CBNA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -286478000.00
CBNA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2530000.00
CBNA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 31000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -5734000.00
CBNA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4629000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 19381000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 289205000.00
CBNA cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 2500000.00
CBNA income_statement (quarterly, 2025-06-30) — Insurance And Claims: 355000.00
CBNA income_statement (quarterly, 2025-06-30) — Interest Expense: 971000.00
CBNA income_statement (quarterly, 2025-06-30) — Interest Income: 12765000.00
CBNA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 950000.00
CBNA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 31175000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 759029000.00
CBNA cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CBNA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 4584000.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Net Interest Income: 11794000.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 18170000.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -364000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Net PPE: 11858000.00
CBNA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -820000.00
CBNA cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 0.00
CBNA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 156948000.00
CBNA income_statement (quarterly, 2025-06-30) — Normalized Income: 4584000.00
CBNA income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 258000.00
CBNA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3350000.00
CBNA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -46000.00
CBNA income_statement (quarterly, 2025-06-30) — Operating Revenue: 12653000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 6561817.00
CBNA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -5734000.00
CBNA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 13000.00
CBNA income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 1471000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 469292000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Payables: 82000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 82000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CBNA income_statement (quarterly, 2025-06-30) — Pretax Income: 5777000.00
CBNA income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 801000.00
CBNA cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -66118000.00
CBNA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -820000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Receivables: 5357000.00
CBNA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 118000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 87832000.00
CBNA income_statement (quarterly, 2025-06-30) — Salaries And Wages: 4274000.00
CBNA cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 84288000.00
CBNA income_statement (quarterly, 2025-06-30) — Selling General And Administration: 4629000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Share Issued: 6561817.00
CBNA cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
CBNA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 156948000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 156948000.00
CBNA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBNA income_statement (quarterly, 2025-06-30) — Tax Provision: 1193000.00
CBNA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CBNA balance_sheet (quarterly, 2025-06-30) — Total Assets: 1445127000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 156948000.00
CBNA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1288179000.00
CBNA cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
CBNA income_statement (quarterly, 2025-09-30) — +Total Revenue: 13134000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 26000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 7082000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7639000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 74785000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 272736000.00
CBNA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 6561817.00
CBNA income_statement (quarterly, 2025-09-30) — Basic EPS: 0.72
CBNA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 377264000.00
CBNA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -322000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 65000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 395683000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 399066000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6628000.00
CBNA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 82626000.00
CBNA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -66987000.00
CBNA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2780000.00
CBNA cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 455000.00
CBNA cash_flow (quarterly, 2025-09-30) — Change In Payable: 455000.00
CBNA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 455000.00
CBNA cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1574000.00
CBNA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1119000.00
CBNA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1574000.00
CBNA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 18419000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Common Stock: 65000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 163096000.00
CBNA cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CBNA cash_flow (quarterly, 2025-09-30) — Depreciation: 116000.00
CBNA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 116000.00
CBNA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 116000.00
CBNA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 6561817.00
CBNA income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.72
CBNA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 4702000.00
CBNA cash_flow (quarterly, 2025-09-30) — End Cash Position: 395683000.00
CBNA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 82626000.00
CBNA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2458000.00
CBNA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 11000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -4288000.00
CBNA income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5015000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 19702000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 283780000.00
CBNA cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1045000.00
CBNA income_statement (quarterly, 2025-09-30) — Insurance And Claims: 349000.00
CBNA income_statement (quarterly, 2025-09-30) — Interest Expense: 1158000.00
CBNA income_statement (quarterly, 2025-09-30) — Interest Income: 13434000.00
CBNA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1214000.00
CBNA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -66987000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 832091000.00
CBNA cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CBNA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 4702000.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Net Interest Income: 12276000.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -70390000.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -4000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Net PPE: 12063000.00
CBNA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -322000.00
CBNA cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
CBNA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 163096000.00
CBNA income_statement (quarterly, 2025-09-30) — Normalized Income: 4702000.00
CBNA income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 267000.00
CBNA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 2780000.00
CBNA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -40000.00
CBNA income_statement (quarterly, 2025-09-30) — Operating Revenue: 13134000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 6561817.00
CBNA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -4288000.00
CBNA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 29000.00
CBNA income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 1485000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 275575000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Payables: 26000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 26000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CBNA income_statement (quarterly, 2025-09-30) — Pretax Income: 5895000.00
CBNA income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 555000.00
CBNA cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -144089000.00
CBNA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -322000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Receivables: 7082000.00
CBNA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 116000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 92534000.00
CBNA income_statement (quarterly, 2025-09-30) — Salaries And Wages: 4666000.00
CBNA cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 73699000.00
CBNA income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5015000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Share Issued: 6561817.00
CBNA cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
CBNA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 163096000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 163096000.00
CBNA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CBNA income_statement (quarterly, 2025-09-30) — Tax Provision: 1193000.00
CBNA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.20
CBNA balance_sheet (quarterly, 2025-09-30) — Total Assets: 1534355000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 163096000.00
CBNA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1371259000.00
CBNA cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -5000.00
CBNA income_statement (annual, 2025-12-31) — +Total Revenue: 55057000.00
CBNA income_statement (quarterly, 2025-12-31) — +Total Revenue: 14699000.00
CBNA balance_sheet (annual, 2025-12-31) — Accounts Payable: 32000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 32000.00
CBNA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 7108000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 7108000.00
CBNA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7755000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7755000.00
CBNA balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 74785000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 74785000.00
CBNA balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 276991000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 276991000.00
CBNA income_statement (annual, 2025-12-31) — Basic Average Shares: 6561817.00
CBNA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 6561817.00
CBNA income_statement (annual, 2025-12-31) — Basic EPS: 3.08
CBNA income_statement (quarterly, 2025-12-31) — Basic EPS: 0.81
CBNA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 410739000.00
CBNA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 395683000.00
CBNA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 12828000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 12828000.00
CBNA cash_flow (annual, 2025-12-31) — Capital Expenditure: -4112000.00
CBNA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1281000.00
CBNA balance_sheet (annual, 2025-12-31) — Capital Stock: 65000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 65000.00
CBNA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 586630000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 586630000.00
CBNA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 590013000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 590013000.00
CBNA balance_sheet (annual, 2025-12-31) — Cash Financial: 4882000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Cash Financial: 4882000.00
CBNA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 323345000.00
CBNA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 208740000.00
CBNA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -163048000.00
CBNA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -24148000.00
CBNA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 15594000.00
CBNA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6355000.00
CBNA cash_flow (annual, 2025-12-31) — Change In Account Payable: 957000.00
CBNA cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1181000.00
CBNA cash_flow (annual, 2025-12-31) — Change In Payable: 957000.00
CBNA cash_flow (quarterly, 2025-12-31) — Change In Payable: 1181000.00
CBNA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 957000.00
CBNA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1181000.00
CBNA cash_flow (annual, 2025-12-31) — Change In Receivables: -2369000.00
CBNA cash_flow (quarterly, 2025-12-31) — Change In Receivables: 315000.00
CBNA cash_flow (annual, 2025-12-31) — Change In Working Capital: -1412000.00
CBNA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1496000.00
CBNA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -2369000.00
CBNA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 315000.00
CBNA cash_flow (annual, 2025-12-31) — Changes In Cash: 175891000.00
CBNA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 190947000.00
CBNA balance_sheet (annual, 2025-12-31) — Common Stock: 65000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Common Stock: 65000.00
CBNA balance_sheet (annual, 2025-12-31) — Common Stock Equity: 169219000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 169219000.00
CBNA cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CBNA balance_sheet (annual, 2025-12-31) — Construction In Progress: 3210000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 3210000.00
CBNA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 6000.00
CBNA cash_flow (annual, 2025-12-31) — Deferred Tax: 6000.00
CBNA cash_flow (annual, 2025-12-31) — Depreciation: 470000.00
CBNA cash_flow (quarterly, 2025-12-31) — Depreciation: 116000.00
CBNA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 470000.00
CBNA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 116000.00
CBNA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 470000.00
CBNA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 116000.00
CBNA income_statement (annual, 2025-12-31) — Diluted Average Shares: 6561817.00
CBNA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 6561817.00
CBNA income_statement (annual, 2025-12-31) — Diluted EPS: 3.08
CBNA income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.81
CBNA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5344000.00
CBNA cash_flow (annual, 2025-12-31) — End Cash Position: 586630000.00
CBNA cash_flow (quarterly, 2025-12-31) — End Cash Position: 586630000.00
CBNA cash_flow (annual, 2025-12-31) — Financing Cash Flow: 323345000.00
CBNA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 208740000.00
CBNA cash_flow (annual, 2025-12-31) — Free Cash Flow: 11482000.00
CBNA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5074000.00
CBNA cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00
CBNA income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 74000.00
CBNA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 5000.00
CBNA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3509000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -3509000.00
CBNA income_statement (annual, 2025-12-31) — General And Administrative Expense: 19798000.00
CBNA income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5223000.00
CBNA balance_sheet (annual, 2025-12-31) — Gross PPE: 20984000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 20984000.00
CBNA balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 256510000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 256510000.00
CBNA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 4755000.00
CBNA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1210000.00
CBNA income_statement (annual, 2025-12-31) — Insurance And Claims: 1455000.00
CBNA income_statement (quarterly, 2025-12-31) — Insurance And Claims: 374000.00
CBNA income_statement (annual, 2025-12-31) — Interest Expense: 4340000.00
CBNA income_statement (quarterly, 2025-12-31) — Interest Expense: 1318000.00
CBNA income_statement (annual, 2025-12-31) — Interest Income: 55843000.00
CBNA income_statement (quarterly, 2025-12-31) — Interest Income: 14903000.00
CBNA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 4355000.00
CBNA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1313000.00
CBNA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -163048000.00
CBNA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -24148000.00
CBNA balance_sheet (annual, 2025-12-31) — Investments And Advances: 865861000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 865861000.00
CBNA cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CBNA balance_sheet (annual, 2025-12-31) — Land And Improvements: 2498000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 2498000.00
CBNA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2448000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2448000.00
CBNA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CBNA income_statement (annual, 2025-12-31) — Net Income: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5344000.00
CBNA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 20237000.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Net Interest Income: 51503000.00
CBNA income_statement (quarterly, 2025-12-31) — Net Interest Income: 13585000.00
CBNA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -196950000.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -32187000.00
CBNA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
CBNA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -514000.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -5000.00
CBNA balance_sheet (annual, 2025-12-31) — Net PPE: 13229000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Net PPE: 13229000.00
CBNA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4112000.00
CBNA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1281000.00
CBNA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CBNA cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CBNA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 169219000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 169219000.00
CBNA income_statement (annual, 2025-12-31) — Normalized Income: 20237000.00
CBNA income_statement (quarterly, 2025-12-31) — Normalized Income: 5344000.00
CBNA income_statement (annual, 2025-12-31) — Occupancy And Equipment: 1072000.00
CBNA income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 296000.00
CBNA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 15594000.00
CBNA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 6355000.00
CBNA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -136000.00
CBNA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -10000.00
CBNA income_statement (annual, 2025-12-31) — Operating Revenue: 55057000.00
CBNA income_statement (quarterly, 2025-12-31) — Operating Revenue: 14699000.00
CBNA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 6561817.00
CBNA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 6561817.00
CBNA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -3509000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -3509000.00
CBNA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 376000.00
CBNA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 5000.00
CBNA income_statement (annual, 2025-12-31) — Other Non Interest Expense: 6041000.00
CBNA income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 1589000.00
CBNA balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 332360000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 332360000.00
CBNA balance_sheet (annual, 2025-12-31) — Payables: 32000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Payables: 32000.00
CBNA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 32000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 32000.00
CBNA balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CBNA balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CBNA income_statement (annual, 2025-12-31) — Pretax Income: 25416000.00
CBNA income_statement (quarterly, 2025-12-31) — Pretax Income: 6706000.00
CBNA income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 3148000.00
CBNA income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 899000.00
CBNA cash_flow (annual, 2025-12-31) — Purchase Of Investment: -626825000.00
CBNA cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -128612000.00
CBNA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4112000.00
CBNA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1281000.00
CBNA balance_sheet (annual, 2025-12-31) — Receivables: 7108000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Receivables: 7108000.00
CBNA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 470000.00
CBNA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 116000.00
CBNA cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
CBNA balance_sheet (annual, 2025-12-31) — Retained Earnings: 97878000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 97878000.00
CBNA income_statement (annual, 2025-12-31) — Salaries And Wages: 18343000.00
CBNA income_statement (quarterly, 2025-12-31) — Salaries And Wages: 4849000.00
CBNA cash_flow (annual, 2025-12-31) — Sale Of Investment: 429875000.00
CBNA cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 96425000.00
CBNA income_statement (annual, 2025-12-31) — Selling General And Administration: 19798000.00
CBNA income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5223000.00
CBNA balance_sheet (annual, 2025-12-31) — Share Issued: 6561817.00
CBNA balance_sheet (quarterly, 2025-12-31) — Share Issued: 6561817.00
CBNA cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
CBNA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 169219000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 169219000.00
CBNA balance_sheet (annual, 2025-12-31) — Tangible Book Value: 169219000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 169219000.00
CBNA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBNA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBNA income_statement (annual, 2025-12-31) — Tax Provision: 5179000.00
CBNA income_statement (quarterly, 2025-12-31) — Tax Provision: 1362000.00
CBNA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
CBNA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
CBNA balance_sheet (annual, 2025-12-31) — Total Assets: 1750399000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Total Assets: 1750399000.00
CBNA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 169219000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 169219000.00
CBNA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 1581180000.00
CBNA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 1581180000.00
CBNA cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -17000.00
CBNA cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: -3000.00
CBNA income_statement (quarterly, 2026-03-31) — +Total Revenue: 17382000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 42000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 10065000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -7899000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 74785000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 283379000.00
CBNA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 6561817.00
CBNA income_statement (quarterly, 2026-03-31) — Basic EPS: 1.08
CBNA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 586630000.00
CBNA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -752000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 65000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 611827000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 615454000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Cash Financial: 7605000.00
CBNA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 161743000.00
CBNA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -140188000.00
CBNA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3642000.00
CBNA cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 876000.00
CBNA cash_flow (quarterly, 2026-03-31) — Change In Payable: 876000.00
CBNA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 876000.00
CBNA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -3453000.00
CBNA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2577000.00
CBNA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -3453000.00
CBNA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 25197000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Common Stock: 65000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 174875000.00
CBNA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 2000.00
CBNA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 2000.00
CBNA cash_flow (quarterly, 2026-03-31) — Depreciation: 144000.00
CBNA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 144000.00
CBNA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 144000.00
CBNA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 6561817.00
CBNA income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.08
CBNA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 7072000.00
CBNA cash_flow (quarterly, 2026-03-31) — End Cash Position: 611827000.00
CBNA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 161743000.00
CBNA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 2890000.00
CBNA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 15000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -4925000.00
CBNA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5440000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 21736000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 246319000.00
CBNA cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CBNA income_statement (quarterly, 2026-03-31) — Insurance And Claims: 411000.00
CBNA income_statement (quarterly, 2026-03-31) — Interest Expense: 595000.00
CBNA income_statement (quarterly, 2026-03-31) — Interest Income: 15544000.00
CBNA cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 585000.00
CBNA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -140188000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1005157000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 7072000.00
CBNA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Net Interest Income: 14949000.00
CBNA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -140448000.00
CBNA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -249000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Net PPE: 13837000.00
CBNA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -752000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 174875000.00
CBNA income_statement (quarterly, 2026-03-31) — Normalized Income: 7072000.00
CBNA income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 326000.00
CBNA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3642000.00
CBNA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -15000.00
CBNA income_statement (quarterly, 2026-03-31) — Operating Revenue: 17382000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 6561817.00
CBNA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -4925000.00
CBNA income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 1693000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 475459000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Payables: 42000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 42000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CBNA income_statement (quarterly, 2026-03-31) — Pretax Income: 8898000.00
CBNA income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 1389000.00
CBNA cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -212430000.00
CBNA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -752000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Receivables: 10065000.00
CBNA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 144000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 104950000.00
CBNA income_statement (quarterly, 2026-03-31) — Salaries And Wages: 5029000.00
CBNA cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 71982000.00
CBNA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5440000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Share Issued: 6561817.00
CBNA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 174875000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 174875000.00
CBNA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CBNA income_statement (quarterly, 2026-03-31) — Tax Provision: 1826000.00
CBNA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
CBNA balance_sheet (quarterly, 2026-03-31) — Total Assets: 1918674000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 174875000.00
CBNA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1743799000.00
CBNA cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 3000.00
CBNK balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 245000.00
CBNK balance_sheet (annual, 2021-12-31) — Current Debt: 10000000.00
CBNK balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 10000000.00
CBNK cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -153000.00
CBNK cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
CBNK balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 10000000.00
CBNK income_statement (annual, 2021-12-31) — Other Gand A: 39237000.00
CBNK income_statement (annual, 2022-12-31) — +Total Revenue: 168277000.00
CBNK balance_sheet (annual, 2022-12-31) — Accounts Payable: 1031000.00
CBNK balance_sheet (annual, 2022-12-31) — Accounts Receivable: 9489000.00
CBNK balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -11508000.00
CBNK balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 58190000.00
CBNK cash_flow (annual, 2022-12-31) — Amortization Of Securities: 540000.00
CBNK income_statement (annual, 2022-12-31) — Basic Average Shares: 14025000.00
CBNK income_statement (annual, 2022-12-31) — Basic EPS: 2.98
CBNK cash_flow (annual, 2022-12-31) — Beginning Cash Position: 183395000.00
CBNK cash_flow (annual, 2022-12-31) — Capital Expenditure: -1550000.00
CBNK balance_sheet (annual, 2022-12-31) — Capital Stock: 141000.00
CBNK balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 59727000.00
CBNK balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 87777000.00
CBNK cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -3085000.00
CBNK balance_sheet (annual, 2022-12-31) — Cash Financial: 19963000.00
CBNK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 44085000.00
CBNK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -198455000.00
CBNK cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 51390000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Account Payable: 558000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -282000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -4382000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -4491000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Payable: 276000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 276000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Receivables: -1588000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Tax Payable: -282000.00
CBNK cash_flow (annual, 2022-12-31) — Change In Working Capital: -10185000.00
CBNK cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -1588000.00
CBNK cash_flow (annual, 2022-12-31) — Changes In Cash: -102980000.00
CBNK balance_sheet (annual, 2022-12-31) — Common Stock: 141000.00
CBNK cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -3085000.00
CBNK balance_sheet (annual, 2022-12-31) — Common Stock Equity: 224015000.00
CBNK cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CBNK balance_sheet (annual, 2022-12-31) — Construction In Progress: 694000.00
CBNK balance_sheet (annual, 2022-12-31) — Current Debt: 10000000.00
CBNK balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 10000000.00
CBNK cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1240000.00
CBNK cash_flow (annual, 2022-12-31) — Deferred Tax: 1240000.00
CBNK cash_flow (annual, 2022-12-31) — Depreciation: 1432000.00
CBNK cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1432000.00
CBNK cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1432000.00
CBNK income_statement (annual, 2022-12-31) — Diluted Average Shares: 14362000.00
CBNK income_statement (annual, 2022-12-31) — Diluted EPS: 2.91
CBNK income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 41804000.00
CBNK cash_flow (annual, 2022-12-31) — End Cash Position: 80415000.00
CBNK cash_flow (annual, 2022-12-31) — Financing Cash Flow: 44085000.00
CBNK cash_flow (annual, 2022-12-31) — Free Cash Flow: 49840000.00
CBNK cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
CBNK cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 14000.00
CBNK income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 0.00
CBNK balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -16751000.00
CBNK income_statement (annual, 2022-12-31) — General And Administrative Expense: 42898000.00
CBNK balance_sheet (annual, 2022-12-31) — Gross PPE: 14894000.00
CBNK cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 11730000.00
CBNK income_statement (annual, 2022-12-31) — Interest Expense: 10039000.00
CBNK income_statement (annual, 2022-12-31) — Interest Income: 150646000.00
CBNK cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 9481000.00
CBNK balance_sheet (annual, 2022-12-31) — Invested Capital: 343077000.00
CBNK cash_flow (annual, 2022-12-31) — Investing Cash Flow: -198455000.00
CBNK balance_sheet (annual, 2022-12-31) — Investments And Advances: 252481000.00
CBNK balance_sheet (annual, 2022-12-31) — Leases: 1683000.00
CBNK balance_sheet (annual, 2022-12-31) — Long Term Debt: 119062000.00
CBNK balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 119062000.00
CBNK balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 7292000.00
CBNK cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CBNK balance_sheet (annual, 2022-12-31) — Net Debt: 59335000.00
CBNK income_statement (annual, 2022-12-31) — Net Income: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 41804000.00
CBNK cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Net Interest Income: 140607000.00
CBNK cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -89232000.00
CBNK cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 85000000.00
CBNK cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 85000000.00
CBNK cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -3758000.00
CBNK balance_sheet (annual, 2022-12-31) — Net PPE: 3386000.00
CBNK cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1550000.00
CBNK balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 224015000.00
CBNK income_statement (annual, 2022-12-31) — Normalized Income: 41804000.00
CBNK income_statement (annual, 2022-12-31) — Occupancy And Equipment: 4865000.00
CBNK cash_flow (annual, 2022-12-31) — Operating Cash Flow: 51390000.00
CBNK cash_flow (annual, 2022-12-31) — Operating Gains Losses: 776000.00
CBNK income_statement (annual, 2022-12-31) — Operating Revenue: 168277000.00
CBNK balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 14138829.00
CBNK balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 10000000.00
CBNK balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -16751000.00
CBNK cash_flow (annual, 2022-12-31) — Other Non Cash Items: 7535000.00
CBNK income_statement (annual, 2022-12-31) — Other Non Interest Expense: 42417000.00
CBNK balance_sheet (annual, 2022-12-31) — Other Properties: 5225000.00
CBNK balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 252481000.00
CBNK balance_sheet (annual, 2022-12-31) — Payables: 1031000.00
CBNK balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1031000.00
CBNK cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 753000.00
CBNK income_statement (annual, 2022-12-31) — Pretax Income: 54234000.00
CBNK cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1235000.00
CBNK income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 11012000.00
CBNK cash_flow (annual, 2022-12-31) — Purchase Of Investment: -113078000.00
CBNK cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1550000.00
CBNK balance_sheet (annual, 2022-12-31) — Receivables: 9489000.00
CBNK income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1432000.00
CBNK cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CBNK balance_sheet (annual, 2022-12-31) — Retained Earnings: 182435000.00
CBNK income_statement (annual, 2022-12-31) — Salaries And Wages: 42898000.00
CBNK cash_flow (annual, 2022-12-31) — Sale Of Investment: 23846000.00
CBNK income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 6220000.00
CBNK income_statement (annual, 2022-12-31) — Selling General And Administration: 49118000.00
CBNK balance_sheet (annual, 2022-12-31) — Share Issued: 14138829.00
CBNK cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1662000.00
CBNK balance_sheet (annual, 2022-12-31) — Stockholders Equity: 224015000.00
CBNK balance_sheet (annual, 2022-12-31) — Tangible Book Value: 224015000.00
CBNK income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CBNK income_statement (annual, 2022-12-31) — Tax Provision: 12430000.00
CBNK income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CBNK balance_sheet (annual, 2022-12-31) — Total Assets: 2123655000.00
CBNK balance_sheet (annual, 2022-12-31) — Total Capitalization: 343077000.00
CBNK balance_sheet (annual, 2022-12-31) — Total Debt: 119062000.00
CBNK balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 224015000.00
CBNK balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1899640000.00
CBNK income_statement (annual, 2023-12-31) — +Total Revenue: 164868000.00
CBNK balance_sheet (annual, 2023-12-31) — Accounts Payable: 5583000.00
CBNK balance_sheet (annual, 2023-12-31) — Accounts Receivable: 11494000.00
CBNK balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -11981000.00
CBNK balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 54473000.00
CBNK cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 0.00
CBNK cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 0.00
CBNK cash_flow (annual, 2023-12-31) — Amortization Of Securities: 188000.00
CBNK balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 123719000.00